Diabetic retinopathy is the leading cause of blindness in working-age adults in the U.S. and is a complication of diabetes.

Diabetic retinopathy is a common complication of diabetes, which manifests as a potentially severe eye disease that can lead ...

Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

Statistical analysis showed a strong association between advanced diabetic retinopathy and an increased likelihood of heart ...

Doctors in India are constantly raising alarms over the rise in cases of vision loss among those battling type 2 ...

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical ...

Researchers at Edith Cowan University (ECU) have developed a cutting-edge Artificial Intelligence (AI) system that could ...

However, left untreated, diabetic retinopathy will steadily get worse over time and start to affect your vision. Treatment can help prevent, delay, and reduce vision loss.

Exonate has announced plans to initiate a phase 2b clinical trial of its lead candidate EXN407, a topical SRPK1 inhibitor, ...

A diabetic eye screening appointment usually takes about 30 minutes: We’ll ask you to read some letters on a chart. We’ll put drops in your eyes. These may sting for a few seconds and may make your ...

Diabetic retinopathy, a type of diabetic eye disease, is one of the leading causes of blindness in the United States. Despite this, almost 40% of people with diabetes don’t get an annual eye exam.

Diabetic retinopathy may not cause any symptoms in its early stages, but as the disease progresses, you may experience changes to your vision, including: Blurred vision Vision that fluctuates ...